Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 10 of 30 for:    Completed Studies | Von Willebrand Disease

Phase II Study of IL-11 (Neumega) in Von Willebrand Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00151125
Recruitment Status : Completed
First Posted : September 8, 2005
Last Update Posted : May 17, 2016
Wyeth is now a wholly owned subsidiary of Pfizer
University of North Carolina
Information provided by (Responsible Party):
Margaret Ragni, University of Pittsburgh

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2007
Actual Study Completion Date : December 2007